Sexual dimorphism in lung transcriptomic adaptations in fetal alcohol spectrum disorders. [PDF]
Naik VD +12 more
europepmc +1 more source
Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects.
Ludmila N. Bakhireva, Daniel D. Savage
openalex +1 more source
A Comparison Among 5 Methods for the Clinical Diagnosis of Fetal Alcohol Spectrum Disorders.
C. Coles +5 more
semanticscholar +1 more source
Perfluorooctane sulfonate (PFOS) exposure disrupts oocyte maturation and early embryonic development. This study elucidates the mechanism by which enhanced O‐GlcNAcylation of FOXK1 underlies the PFOS‐induced reduction of progesterone levels in granulosa cells and the disturbance of follicular microenvironment.
Shuwen Han +16 more
wiley +1 more source
Understanding the Determinants of Use of the Australian Guide to Diagnosis of Fetal Alcohol Spectrum Disorder: Informing the Review, Development and Dissemination of New National Clinical Practice Guidelines. [PDF]
Reid N +6 more
europepmc +1 more source
The Genetics of Fetal Alcohol Spectrum Disorders.
J. Eberhart, S. Parnell
semanticscholar +1 more source
Bioinspired Tissue Transparency: Achieving Sclera‐to‐Cornea Transplantation
A bioinspired decellularization‐compression‐locking tactic (DCLT) is developed to transform human sclerae into transparent corneal substitutes. These clear, robust, and pro‐regenerative substitutes are capable of repairing complex corneal injuries, including chemical burns, keratoconus, and penetrating wounds, demonstrating their clinical potential to ...
Xiuli Sun +8 more
wiley +1 more source
Trigeminal nerve stimulation (TNS) for children with attention deficit/hyperactivity disorder and fetal alcohol spectrum disorder: Feasibility study protocol. [PDF]
O'Neill J +5 more
europepmc +1 more source
This study shows that integrin receptor CD49a (Itga1 gene) is significantly upregulated in hyperactivated microglia and microglia‐specific knockdown of Itga1 rescues neuroinflammation and neurodegeneration in a chronic Parkinson's disease (PD) model by targeting PGAM5‐mediated mitochondrial dysfunction and NLRP3 activation. Targeted inhibition of CD49a
Huanpeng Lu +6 more
wiley +1 more source

